News

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Experts warn about risks of new COVID-19 vaccine guidelines 04:32. The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for ...